Statement of Changes in Beneficial Ownership (4)
February 18 2015 - 6:38PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Williams Michael J PhD
|
2. Issuer Name
and
Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE
[
IDXX
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
Executive Vice President
|
(Last)
(First)
(Middle)
ONE IDEXX DRIVE
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
2/14/2015
|
(Street)
WESTBROOK, ME 04092
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
2/14/2015
|
|
M
|
|
202
|
A
|
$0
|
14279
(1)
|
D
|
|
Common Stock
|
2/14/2015
|
|
M
|
|
273
|
A
|
$0
|
14552
|
D
|
|
Common Stock
|
2/14/2015
|
|
M
|
|
257
|
A
|
$0
|
14809
|
D
|
|
Common Stock
|
2/14/2015
|
|
M
|
|
258
|
A
|
$0
|
15067
|
D
|
|
Common Stock
|
2/14/2015
|
|
M
|
|
398
|
A
|
$0
|
15465
|
D
|
|
Common Stock
|
2/14/2015
|
|
F
|
|
121
|
D
|
$159.08
|
15344
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Non-Qualified Stock Option (right to buy)
|
$159.08
|
2/14/2015
|
|
A
|
|
13424
|
|
(2)
|
2/13/2025
|
Common Stock
|
13424
|
$0
|
13424
|
D
|
|
Incentive Stock Option (right to buy)
|
$159.08
|
2/14/2015
|
|
A
|
|
628
|
|
(3)
|
2/13/2025
|
Common Stock
|
628
|
$0
|
628
|
D
|
|
Restricted Stock Unit
|
(4)
|
2/14/2015
|
|
A
|
|
1179
|
|
(4)
|
(4)
|
Common Stock
|
1179
|
$0
|
9482
|
D
|
|
Restricted Stock Unit
|
(5)
|
2/14/2015
|
|
M
|
|
|
202
|
(5)
|
(5)
|
Common Stock
|
202
|
$0
|
9280
|
D
|
|
Restricted Stock Unit
|
(6)
|
2/14/2015
|
|
M
|
|
|
273
|
(6)
|
(6)
|
Common Stock
|
273
|
$0
|
9007
|
D
|
|
Restricted Stock Unit
|
(7)
|
2/14/2015
|
|
M
|
|
|
257
|
(7)
|
(7)
|
Common Stock
|
257
|
$0
|
8750
|
D
|
|
Restricted Stock Unit
|
(8)
|
2/14/2015
|
|
M
|
|
|
258
|
(8)
|
(8)
|
Common Stock
|
258
|
$0
|
8492
|
D
|
|
Restricted Stock Unit
|
(9)
|
2/14/2015
|
|
M
|
|
|
398
|
(9)
|
(9)
|
Common Stock
|
398
|
$0
|
8094
|
D
|
|
Explanation of Responses:
|
(
1)
|
Includes 44 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 12/31/2014.
|
(
2)
|
Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that becomes exercisable as to 2,811 shares on 02/14/2016 and 02/14/2017, 2,810 shares on 02/14/2018 and 02/14/2019, and the remaining 2,182 shares on 02/14/2020.
|
(
3)
|
Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests on the fifth anniversary date (02/14/2020) of the grant.
|
(
4)
|
Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2016) of the date of grant.
|
(
5)
|
Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2015) of the date of grant.
|
(
6)
|
Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2014) of the date of grant.
|
(
7)
|
Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.
|
(
8)
|
Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.
|
(
9)
|
Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Williams Michael J PhD
ONE IDEXX DRIVE
WESTBROOK, ME 04092
|
|
|
Executive Vice President
|
|
Signatures
|
Lily J. Lu, Attorney-in-Fact for Michael J. Williams, PhD
|
|
2/18/2015
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
IDEXX Laboratories (NASDAQ:IDXX)
Historical Stock Chart
From Aug 2024 to Sep 2024
IDEXX Laboratories (NASDAQ:IDXX)
Historical Stock Chart
From Sep 2023 to Sep 2024